dual Syk/JAK inhibitors (Nicox Ophthalmics)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual Syk/JAK inhibitors (Nicox Ophthalmics)
Drug Alias Namedual Syk/JAK inhibitors (Aciex/Portola)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinaseJanus kinase
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPortola Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox Ophthalmics IncPortola Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOcular inflammation

Other Information

ATC CodeN/A
Related LinksN/A